Doreen Chan

2.4k total citations · 3 hit papers
23 papers, 1.7k citations indexed

About

Doreen Chan is a scholar working on Biomedical Engineering, Molecular Biology and Surgery. According to data from OpenAlex, Doreen Chan has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomedical Engineering, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Doreen Chan's work include Liver Disease Diagnosis and Treatment (5 papers), Fibroblast Growth Factor Research (4 papers) and Advanced Sensor and Energy Harvesting Materials (4 papers). Doreen Chan is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Fibroblast Growth Factor Research (4 papers) and Advanced Sensor and Energy Harvesting Materials (4 papers). Doreen Chan collaborates with scholars based in United States, United Kingdom and Denmark. Doreen Chan's co-authors include Eric A. Appel, Anthony C. Yu, Hector Lopez Hernandez, Lyndsay M. Stapleton, Abigail K. Grosskopf, Santiago Correa, Eneko Axpe, Giovanni S. Offeddu, David Mérida and Caitlin L. Maikawa and has published in prestigious journals such as New England Journal of Medicine, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

Doreen Chan

21 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Translational Applications of Hydrogels

2021 775 citations Santiago Correa, Abigail K. Grosskopf et al. Chemical Reviews profile →
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

2023 146 citations Stephen A. Harrison, Juan P. Frías et al. The Lancet. Gastroenterology & hepatology profile →
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH

2025 19 citations Mazen Noureddin, Guy Neff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doreen Chan United States	16	590	473	455	290	179	23	1.7k
Anthony C. Yu United States	19	605 1.0×	615 1.3×	492 1.1×	332 1.1×	57 0.3×	34	1.9k
Huacheng He China	27	690 1.2×	747 1.6×	226 0.5×	314 1.1×	88 0.5×	50	2.2k
Shigeki Suzuki Japan	20	713 1.2×	402 0.8×	732 1.6×	640 2.2×	104 0.6×	71	2.6k
Lyndsay M. Stapleton United States	15	510 0.9×	460 1.0×	379 0.8×	243 0.8×	38 0.2×	23	1.4k
Aixi Yu China	29	1.1k 1.8×	700 1.5×	203 0.4×	541 1.9×	113 0.6×	121	2.7k
Rixing Zhan China	21	551 0.9×	708 1.5×	131 0.3×	494 1.7×	109 0.6×	47	2.2k
Jiang Wu China	35	1.1k 1.8×	1.2k 2.5×	414 0.9×	627 2.2×	97 0.5×	90	3.7k
Zujian Feng China	24	1.0k 1.7×	832 1.8×	229 0.5×	340 1.2×	40 0.2×	51	2.2k
Jennifer H. Ward United States	17	503 0.9×	424 0.9×	516 1.1×	322 1.1×	27 0.2×	27	1.7k
Linyu Long China	21	748 1.3×	1.2k 2.6×	371 0.8×	268 0.9×	31 0.2×	35	2.6k

Countries citing papers authored by Doreen Chan

Since Specialization

Citations

This map shows the geographic impact of Doreen Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doreen Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doreen Chan more than expected).

Fields of papers citing papers by Doreen Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doreen Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doreen Chan. The network helps show where Doreen Chan may publish in the future.

Co-authorship network of co-authors of Doreen Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Doreen Chan. A scholar is included among the top collaborators of Doreen Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doreen Chan. Doreen Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noureddin, Mazen, Juan P. Frías, Guy Neff, et al.. (2025). Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet. 406(10504). 719–730. 5 indexed citations

Noureddin, Mazen, Mary E. Rinella, Naga Chalasani, et al.. (2025). GS-012 Efruxifermin improves fibrosis in participants with compensated cirrhosis due to MASH: results of a 96-week, randomized, doubleblind, placebo-controlled, phase 2b trial (SYMMETRY). Journal of Hepatology. 82. S8–S9.

Lucas, Kathryn Jean, Doreen Chan, Erik J. Tillman, et al.. (2024). 897-P: Insulin-Sensitizing Effects of Efruxifermin Improve Glycemic Control in Patients with MASH and Type 2 Diabetes. Diabetes. 73(Supplement_1). 1 indexed citations

Harrison, Stephen A., Juan P. Frías, Kathryn Jean Lucas, et al.. (2024). Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study. Clinical Gastroenterology and Hepatology. 23(1). 103–113. 37 indexed citations

Chan, Doreen, Caitlin L. Maikawa, Andrea I. d’Aquino, et al.. (2023). Polyacrylamide‐based hydrogel coatings improve biocompatibility of implanted pump devices. Journal of Biomedical Materials Research Part A. 111(7). 910–920. 20 indexed citations

Harrison, Stephen A., Juan P. Frías, Guy Neff, et al.. (2023). Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet. Gastroenterology & hepatology. 8(12). 1080–1093. 146 indexed citations breakdown →

Thakore, Akshara D., Yuko Tada, Albert J Pedroza, et al.. (2022). Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling. Scientific Reports. 12(1). 17605–17605. 8 indexed citations

Chan, Doreen, Jun‐Chau Chien, Eneko Axpe, et al.. (2022). Combinatorial Polyacrylamide Hydrogels for Preventing Biofouling on Implantable Biosensors. Advanced Materials. 34(24). e2109764–e2109764. 135 indexed citations

Yu, Anthony C., et al.. (2021). More than a fertilizer: wastewater-derived struvite as a high value, sustainable fire retardant. Green Chemistry. 23(12). 4510–4523. 32 indexed citations

10.

Correa, Santiago, Abigail K. Grosskopf, Hector Lopez Hernandez, et al.. (2021). Translational Applications of Hydrogels. Chemical Reviews. 121(18). 11385–11457. 775 indexed citations breakdown →

11.

Maikawa, Caitlin L., Anton A. A. Smith, Lei Zou, et al.. (2020). A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs. Nature Biomedical Engineering. 4(5). 507–517. 54 indexed citations

12.

Axpe, Eneko, Doreen Chan, Ann‐Sofie Schreurs, et al.. (2020). A human mission to Mars: Predicting the bone mineral density loss of astronauts. PLoS ONE. 15(1). e0226434–e0226434. 23 indexed citations

13.

Mann, Joseph L., Caitlin L. Maikawa, Anton A. A. Smith, et al.. (2020). An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients. Science Translational Medicine. 12(550). 46 indexed citations

14.

Steele, Amanda N., Lyndsay M. Stapleton, Justin M. Farry, et al.. (2019). A Biocompatible Therapeutic Catheter‐Deliverable Hydrogel for In Situ Tissue Engineering. Advanced Healthcare Materials. 8(5). e1801147–e1801147. 54 indexed citations

15.

Yu, Anthony C., Hector Lopez Hernandez, Lyndsay M. Stapleton, et al.. (2019). Wildfire prevention through prophylactic treatment of high-risk landscapes using viscoelastic retardant fluids. Proceedings of the National Academy of Sciences. 116(42). 20820–20827. 37 indexed citations

16.

Axpe, Eneko, Doreen Chan, Giovanni S. Offeddu, et al.. (2019). A Multiscale Model for Solute Diffusion in Hydrogels. Macromolecules. 52(18). 6889–6897. 182 indexed citations

17.

Chan, Doreen, Anthony C. Yu, & Eric A. Appel. (2017). Single-Chain Polymeric Nanocarriers: A Platform for Determining Structure–Function Correlations in the Delivery of Molecular Cargo. Biomacromolecules. 18(4). 1434–1439. 15 indexed citations

18.

Chan, Doreen, Yichuan Ding, Reinhold H. Dauskardt, & Eric A. Appel. (2017). Engineering the Mechanical Properties of Polymer Networks with Precise Doping of Primary Defects. ACS Applied Materials & Interfaces. 9(48). 42217–42224. 24 indexed citations

19.

Yu, Anthony C., Haoxuan Chen, Doreen Chan, et al.. (2016). Scalable manufacturing of biomimetic moldable hydrogels for industrial applications. Proceedings of the National Academy of Sciences. 113(50). 14255–14260. 99 indexed citations

20.

Chan, Doreen, et al.. (2004). Intervertebral disc regeneration by use of autologous mesenchymal stem cells, an experimental model in rabbits. The HKU Scholars Hub (University of Hong Kong).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact